Neuroscience research is incredibly complex, but the strategic use of biomarkers is unlocking transformative potential for novel therapies. In a new International Clinical Trials article, Worldwide Clinical Trials’ Richard Bennett and Peter Böhm explore the critical benefits and challenges of integrating these tools into your development programs. They detail how biomarkers can drive earlier diagnosis, predict disease progression, improve patient stratification, and accelerate development timelines when managed with rigorous operational foresight and collaboration. Read their article on pages 66-69 to learn more about navigating this new frontier and advancing your neuroscience clinical trials.
